Global Radiopharmaceutical Network
Nuclear Medicine Infrastructure
Connecting Infrastructure,
Expertise & Innovation in
Radiopharmaceuticals
From cyclotron infrastructure and radiopharmacy to PET/CT infrastructure and radioisotope production, Global CanCare connects healthcare providers with the technologies, expertise and global partners needed for successful nuclear medicine facility development.
End-to-End Project Support
Global Network of Specialist Partners
Regulatory & Quality Focus
Future-Ready Solutions
Access to Global Technology
Best-in-class equipment partners
Safety & Compliance
At every project step
Optimized Workflows
Efficiency by design
Expertise That Drives Success
Scalable long-term growth
Who We Are
Nuclear Medicine Solutions for Modern Healthcare
Global CanCare helps hospitals, cancer centres and healthcare organisations develop advanced nuclear medicine infrastructure through a global ecosystem of specialist partners.
Whether you're establishing a new nuclear medicine facility, expanding existing capabilities or introducing advanced molecular imaging and theranostic services, we support every stage of nuclear medicine project development—connecting the right expertise, technologies and infrastructure from planning through implementation.
Facility Development
Infrastructure Planning
Radiopharmacy
Molecular Imaging
Cyclotron Solutions
Radioisotope Production
Industry Snapshot
The Growing Need for Nuclear Medicine Infrastructure
Demand for molecular imaging, radiopharmaceuticals and targeted radionuclide therapies continues to grow worldwide.
Nuclear Medicine: A Market Growing. A Future Transforming.
USD 21.3B → 38.2B
The global nuclear medicine market is projected to grow from USD 21.3 billion in 2025 to USD 38.2 billion by 2033, driven by rising demand for precision diagnostics, theranostics and radiopharmaceuticals.
Source: Grand View Research, 2026
20× (2,000%)
Radiopharmaceutical therapy use among Medicare patients increased more than 20-fold between 2013 and 2023 (from 529 to 12,395 administrations), highlighting the rapid expansion of nuclear medicine infrastructure and multidisciplinary cancer care.
Source: ASTRO / Radiology Business, 2026
US$1B+
Radiopharmaceuticals have entered the blockbuster era, with leading therapies generating over US$1 billion in annual sales.
Source: CERN Courier, 2026
Nuclear medicine is evolving fast - driving better outcomes, shaping the future of Cancer Care, and creating new opportunities for healthcare systems worldwide.
Developing these programmes requires specialised infrastructure, regulatory planning, coordinated project execution and trusted technology partners.
Our Capabilities
Nuclear Medicine Infrastructure Solutions
Cyclotron Infrastructure
We provide end-to-end consulting for cyclotron infrastructure planning and medical isotope production facilities. Our services span from initial site feasibility studies and shielding design to GMP-compliant laboratory layouts, radiation safety evaluations, and navigating regulatory compliance.
Radiopharmacy Solutions
We help build and optimize GMP-compliant radiopharmacy facilities and radiopharmaceutical manufacturing workflows. Our team provides specialized development support to ensure your operations meet strict regulatory standards, achieve seamless production, and maintain uncompromised quality control from design to daily execution.
PET/CT Infrastructure
We specialize in PET/CT infrastructure integration and clinical workflow optimization. Our consultants partner with medical facilities to design, plan, and deploy advanced molecular imaging environments, helping you maximize ROI, ensure radiation safety, and streamline daily operations.
Radioisotope Production
We scale your radioisotope production capabilities by connecting projects with specialist expertise and a global partner network to overcome technical, supply chain, and regulatory hurdles.
Why Global CanCare?
A Trusted Partner for Nuclear Medicine Project Development
Global CanCare brings together specialist partners, advanced technologies and end-to-end project expertise to help healthcare providers build safe, compliant and future-ready nuclear medicine programmes.
Book a Free ConsultationGlobal Ecosystem
A worldwide network of specialist partners across nuclear medicine and oncology infrastructure.
Regulatory & Quality Focus
GMP-compliant planning, radiation safety and regulatory support at every step.
End-to-End Coordination
One partner to align cyclotron suppliers, imaging vendors, shielding specialists and engineers.
Future-Ready Solutions
Infrastructure designed for theranostics, molecular imaging and long-term scalability.
Frequently Asked Questions
Nuclear Medicine Infrastructure FAQs
Global CanCare Ecosystem
Nuclear Medicine Within a Connected Cancer Care Ecosystem
The Global Radiopharmaceutical Network connects nuclear medicine infrastructure with AI imaging, radiotherapy, radiation shielding and specialised oncology services - helping healthcare providers build more integrated Cancer Care programmes.